← Return to Anyone on Pluvicto (Lu 177), a new drug for prostate cancer?

Discussion

Anyone on Pluvicto (Lu 177), a new drug for prostate cancer?

Prostate Cancer | Last Active: Feb 27 9:46am | Replies (171)
Comment receiving replies
@scv57

I've just started my prostate cancer treatment journey.(Xtandi) You may find this Prostate Cancer Research Institute video helpful.

PSMA Scans & Pluvicto (lutetium-177) in 2022 | Geoffrey Johnson, MD, PhD | PCRI Conference 2022

Hopefully the 177 Lutetium PSMA is sucessful but in the mean time look into the 225-Actinium PSMA-617

Jump to this post

Replies to "I've just started my prostate cancer treatment journey.(Xtandi) You may find this Prostate Cancer Research Institute..."
Colleen Young, Connect Director | @colleenyoung | Feb 3, 2023

@scv57, welcome. I noticed that you wished to post a URL to a video from the Prostate Cancer Research Institute with your post. You will be able to add URLs to your posts in a few days. There is a brief period where new members can't post links. We do this to deter spammers and keep the community safe. Clearly the link you wanted to post is not spam. Members appreciate the informative videos from Prostate Cancer Research Institute. Please allow me to post it for you.

This video features Geoffrey Johnson, MD, Ph.D., is a radiologist specializing in nuclear medicine at the Mayo Clinic in Rochester, Minnesota. Here, he discusses PET/CT scans and new "theranostics" treatments for prostate cancer, including the newly approved "Pluvicto" (lutetium-177).

VIEW AND REPLY